Repro-Med Systems and Omni Biomed LLC Sign Distribution Agreement for Marketing the Freedom60 Infusion System and the Res-Q-Vac
11 Mai 2004 - 11:31PM
PR Newswire (US)
Repro-Med Systems and Omni Biomed LLC Sign Distribution Agreement
for Marketing the Freedom60 Infusion System and the Res-Q-Vac
Suction System CHESTER, N.Y., May 11 /PRNewswire-FirstCall/ --
Repro-Med Systems Inc. (BULLETIN BOARD: REPR) announced today a
distribution agreement with Omni Biomed based in Knoxville,
Tennessee. Repro-Med Systems develops and manufactures high
performance, low cost medical devices. Omni Biomed LLC services
hospitals, physicians, clinics and home and long term care markets
in the South East United States. The agreement covers the Freedom60
Syringe Infusion System and the Res-Q-Vac Airway Suction System for
the South Eastern United States including Tennessee, Kentucky,
Alabama, Arkansas, North Carolina, South Carolina, Mississippi,
Louisiana, West Virginia, Virginia, Georgia, and Florida. "It is
with great excitement that we announce our agreement with Omni
Biomed which presents a unique opportunity in the infusion market
for our Freedom60," comments Andy Sealfon, President of Repro-Med
Systems, Inc. "Omni brings together experience not only in
distribution, but also operates their own pharmacy and has direct
user experience with the Freedom60 on patients. This provides
essential technical and financial knowledge of infusion delivery to
support their marketing. They already service hundreds of nursing
homes and home care centers in the Southeast, which will also
facilitate introducing our Res-Q-Vac to the home care market."
Sealfon added. Ron Sherrill, President of Omni Healthcare said, "We
are delighted to become a distributor for Repro-Med products. Our
customers have already had positive results from the Freedom60.
Adding the Res-Q-Vac will help us in developing new markets as well
as expanding existing markets." Acceptance of the Freedom60 Syringe
System has been accelerated in domestic and global markets with
documented applications for vancomycin and desferal. In Europe, the
Freedom60 has made great progress in treating pain via epidural
administration. Omni's staff of clinical pharmacists and nurses,
will introduce the Freedom60 to these cases in the United States.
Omni's presence in the home care and nursing home market will
enable it to introduce the Res-Q-Vac for patients needing routine
suction at home or in long term care -- or anyone requiring airway
suction maintenance. The use of Res-Q-Vac is expanding into home
care and hospitals due to the addition of Full Stop Protection,
which prevents any infection or contamination from exiting the
system, thus protecting the health care professionals and the
public at large. Protection against the spread of disease is
mandated by OSHA law and indicated in the CDC guidelines. Hospitals
have been encouraged to provide isolation for the treatment of
potentially infected patients such as those suspected having SARS,
tuberculosis, AIDS/HIV, etc., all of which can be safely and cost
effectively treated in isolation using the filtered Res-Q-Vac. For
more information call: Repro-Med Systems, Inc. Andrew Sealfon
800-624-9600 x307 http://www.repro-med.com/ DATASOURCE: Repro-Med
Systems Inc. CONTACT: Andrew Sealfon of Repro-Med Systems,
1-800-624-9600, ext. 307, Web site: http://www.repro-med.com/
Copyright